News List

Biotech accelerator IndieBio-backed startups gain exclusive access to customized Science Exchange outsourced R&D platform

IndieBio, one of the world’s largest seed biotech accelerator, enters agreement to give its startups access to the Science Exchange network of more than 2,500 qualified scientific service providers

By Team ABLE

US-located Science Exchange, the world’s leading platform for outsourced research and development (R&D), has announced a strategic partnership with IndieBio, the world’s largest seed biotech accelerator.

IndieBio-backed companies will now have exclusive access to a customized Science Exchange-powered marketplace, where they can instantly order R&D services from a network of more than 2,500 qualified scientific service providers.

“We are always looking for the right mix of resources to support the success of our biotech companies. The Science Exchange platform will give them access to a premier set of research services, along with contracting support to protect companies’ intellectual property and confidentiality,” said Jun Axup, Ph.D. and science director of IndieBio. “We want our biotech companies to succeed, and at the same time see the industry as a whole move faster and discover cures to more diseases. With Science Exchange, the companies in our program now have access to wide range of services, such as comparative data, chemical synthesis and next-gen sequencing, which will help them move their projects ahead more quickly and cost-effectively.”

IndieBio is best known for its investments in innovative startups with a focus on biology as a technology. Companies from all over the world apply to be part of IndieBio’s four-month acceleration program, which includes funding, dedicated mentorship and 24/7 access to a co-working space and bio-safety labs. IndieBio companies solve problems across a wide range of industries, such as the future of food, biopharma and healthcare, agtech, regenerative medicine, neurotech and biomaterials.

This partnership addresses the unique needs of IndieBio’s R&D-focused startups, leveling the playing field with Science Exchange’s established global pharmaceutical and biotechnology clients by giving IndieBio’s startups ready access to the expertise and infrastructure found within the Science Exchange network of service providers.

Under the partnership, all service providers on the IndieBio-Science Exchange network are available under a single contract that protects IP and confidentiality. Science Exchange\'s in-house audit team also conducts inspections to ensure that contracted service providers possess necessary certifications, licenses, informed consent of subjects, and data security.

It is believed that the Science Exchange-powered IndieBio platform will enable companies to quickly identify cost-competitive outsourced R&D options, including access to special offers exclusive to IndieBio-funded companies.
IndieBio joins more than 30 enterprise clients that are efficiently managing their outsourced R&D with Science Exchange-powered marketplaces.